产品分类
联系我们
湖北成丰化工有限公司
 机:18627907091
 话:027-5922-8931
 真:027-5922-8931
 箱:648231588@qq.com
 址:http://show.guidechem.com/zuoteng2011
 址:武汉市东西湖区辛安渡工业园43号
咪唑 分析纯试剂 AR100g
物品单位 品牌
成丰
  • 产地:湖北
  • 货号:20210369
  • cas:288-32-4
  • 发布日期: 2021-05-20
  • 更新日期: 2022-02-08
产品详细说明
产地 湖北
品牌 成丰
货号 20210369
用途 分析纯
产品规格 500g/瓶
CAS编号 288-32-4
纯度 99%%
是否进口

咪唑分析纯试剂AR100g

288-32-4 咪唑

3D结构式查看
  • CAS:288-32-4
  • 分子式:C3H4N2
  • 分子量:68.079
化合物别名
  • 中文别名
    甘噁啉; 甘恶啉; 咁噁啉; 间二氮茂; 1,3-二氮唑; 1,3-二氮杂环戊二烯; 1,3-二氮杂-2,4-环戊二烯; 1,3-二氨杂环戊二烯; 咪唑 (区域精制法精制,熔段数:30); 咪唑 [荧光分析用]; 咪唑 [缓冲液用]; 咪唑;
  • 英文名称
    Imidazole
  • 英文别名
    {pyrro[b]monazole}; 1,3-diaza-2,4-cyclopentadiene; 1,3-diaza-2,4-cyclopentadiene-; 1,3-diazole; 1,4-cyclopentadiene; 1h-imidazole; 1h-imidazole (9ci); 2519-EP2269991A2; 2519-EP2269978A2; 2519-EP2270113A1; 2519-EP2269977A2; 2519-EP2269985A2; 2519-EP2269992A1; 2519-EP2272510A1; 2519-EP2270008A1; 2519-EP2270505A1; 142240-EP2270010A1; 2519-EP2270010A1; 2519-EP2270011A1; 2519-EP2270006A1; 142240-EP2292593A2; 2519-EP2269990A1; 2519-EP2270014A1; 2519-EP0930075A1; 2519-EP1441224A2; 1-h-imidazole; 2519-EP2270015A1; 2519-EP2270002A1; 2519-EP2272509A1; 1h-imidazol; 2,4-diazonia-2,4-cyclopentadiene-1-ide; 2519-EP2272848A1; 2519-EP2281815A1; 2519-EP2272838A1; 2519-EP2281824A1; 2519-EP2274983A1; 2519-EP2272817A1; 2519-EP2284156A2; 2519-EP2280005A1; 2519-EP2272935A1; 2519-EP2275413A1; 2519-EP2272516A2; 2519-EP2284169A1; 2519-EP2284151A2; 2519-EP2277880A1; 2519-EP2272832A1; 2519-EP2272813A2; 2519-EP2275102A1; 2519-EP2277872A1; 2519-EP2284157A1; 2519-EP2272972A1; 2519-EP2280000A1; 2519-EP2272828A1; 2519-EP2272827A1; 2519-EP2275404A1; 2519-EP2272973A1; 2519-EP2275414A1; 2519-EP2281819A1; 2519-EP2284150A2; 2519-EP2275409A1; 2519-EP2284149A1; 2519-EP2272825A2; 2519-EP2275412A1; 2519-EP2272849A1; 2519-EP2281563A1; 2519-EP2284155A2; 2519-EP2275395A2; 2519-EP2281813A1; 2519-EP2277858A1; 2519-EP2272517A1; 2519-EP2272839A1; 2519-EP2272841A1; 2519-EP2272537A2; 2519-EP2277848A1; 2519-EP2284153A2; 2519-EP2281818A1; 2519-EP2275401A1; 2519-EP2272840A1; 2519-EP2280009A1; 2519-EP2284152A2; 2519-EP2275411A2; 2519-EP2284164A2; 2519-EP2276085A1; 2519-EP2305643A1; 2519-EP2301930A1; 2519-EP2305658A1; 2519-EP2301538A1; 2519-EP2298743A1; 2519-EP2301913A1; 2519-EP2298755A1; 2519-EP2301912A2; 2519-EP2305640A2; 2519-EP2298763A1; 2519-EP2301916A2; 2519-EP2298774A1; 2519-EP2301536A1; 2519-EP2301931A1; 2519-EP2292612A2; 2519-EP2298744A2; 2519-EP2295426A1; 2519-EP2305637A2; 2519-EP2301914A1; 2519-EP2292619A1; 2519-EP2301933A1; 2519-EP2305648A1; 2519-EP2301918A1; 2519-EP2287167A1; 2519-EP2287148A2; 2519-EP2298731A1; 2519-EP2301935A1; 2519-EP2305689A1; 2519-EP2286915A2; 2519-EP2305659A1; 2519-EP2301983A1; 2519-EP2295406A1; 2519-EP2292604A2; 2519-EP2292617A1; 2519-EP2289890A1; 2519-EP2298767A1; 2519-EP2298742A1; 2519-EP2299509A1; 2519-EP2292590A2; 2519-EP2295432A1; 2519-EP2292620A2; 2519-EP2298770A1; 2519-EP2295415A1; 2519-EP2289868A1; 2519-EP2292606A1; 2519-EP2298772A1; 2519-EP2289894A2; 2519-EP2292611A1; 2519-EP2301929A1; 2519-EP2295434A2; 2519-EP2287162A1; 2519-EP2292592A1; 2519-EP2286812A1; 2519-EP2305668A1; 2519-EP2298778A1; 2519-EP2298766A1; 2519-EP2305250A1; 2519-EP2298828A1; 2519-EP2295419A2; 2519-EP2305674A1; 2519-EP2287165A2; 2519-EP2295421A1; 2519-EP2289884A1; 2519-EP2295550A2; 2519-EP2301921A1; 2519-EP2292613A1; 2519-EP2301932A1; 2519-EP2301926A1; 2519-EP2295402A2; 2519-EP2292596A2; 2519-EP2287166A2; 2519-EP2305695A2; 2519-EP2301940A1; 2519-EP2295414A1; 2519-EP2295427A1; 2519-EP2305657A2; 2519-EP2295401A2; 2519-EP2301937A1; 2519-EP2305652A2; 2519-EP2298732A1; 2519-EP2305651A1; 2519-EP2300438A1; 2519-EP2305219A1; 2519-EP2292630A1; 2519-EP2295433A2; 2519-EP2292597A1; 2519-EP2305676A1; 2519-EP2302003A1; 2519-EP2287150A2; 2519-EP2292610A1; 2519-EP2284920A1; 2519-EP2298783A1; 2519-EP2292586A2; 2519-EP2292593A2; 2519-EP2287161A1; 2519-EP2295429A1; 2519-EP2305682A1; 2519-EP2292621A1; 2519-EP2301534A1; 2519-EP2298776A1; 2519-EP2302015A1; 2519-EP2287140A2; 2519-EP2301934A1; 2519-EP2289871A1; him; IMD; RAXXELZNTBOGNW-UHFFFAOYSA-N; glyoxalin; nsc-60522; formamidine,n'-vinylene-; imutex; wln: t5m cnj; nsc60522; usaf ek-4733; nsc51860; n,n'-vinyleneformamidine; pyrro[b]monazole; imidazole (8ci); ai3-24703; miazole; iminazole; methanimidamide, n,n'-1,2-ethenediyl-; n,n'-1,2-ethenediylmethanimidamide; glyoxaline; ccris 3345; methanimidamide,n'-1,2-ethenediyl-; CHEBI:16069; NCISTRUC2_000693; NCISTRUC1_001975; NCGC00090984-01; chembl540; bdbm7882; imidazole, for molecular biology, >=99% (titration); C01589; pyrro(b)monazole; imidazole, >=99% (titration), crystalline; imidazole, acs reagent, >=99% (titration); DB03366; imidazol-1-yl group; formamidine, n,n'-vinylene-; imidazol-2-yl group; imidazol-4-yl group; nsc 51860; nsc 60522; LS-77964; einecs 206-019-2; TL8002274; glioksal [polish]; brn 0103853; imidazole, puriss. p.a., >=99.5% (gc); imidazole, bioultra, >=99.5% (gc); STK362967; MLS001055465; smr000057825; imidazole, bioultra, for molecular biology, >=99.5% (gc); imidazole buffer solution, bioultra, 1 m in h2o; imidazol; BMSE000096; I14-0665; 4286D518-643C-4C69-BCE7-519D073F4992; I0001; I14-10573; I0288; I0014; I0290; AC1L1A1H; MOLPORT-000-156-418; AKOS000120177; imidazole; glyoxaline; unavailable - see asdi_catno 500012277; AB1002136; BB_SC-6938; AC1Q4W12; AC1Q4W13; ST097249; 59390-EP2371806A1; BBL009685; 2519-EP2311815A1; 2519-EP2311796A1; 2519-EP2316450A1; 2519-EP2308848A1; 2519-EP2308510A1; 2519-EP2311841A1; 2519-EP2308812A2; 2519-EP2308877A1; 2519-EP2316452A1; 2519-EP2308840A1; 2519-EP2308883A1; 2519-EP2308872A1; 2519-EP2372804A1; 2519-EP2311799A1; 2519-EP2308880A1; 2519-EP2377847A1; 2519-EP2372017A1; I14-22650; NCGC00090984-02; 59390-EP2270011A1; 59390-EP2305808A1; 59390-EP2308852A1; 2519-EP2316829A1; 2519-EP2308854A1; 2519-EP2314587A1; 2519-EP2314583A1; 2519-EP2316836A1; 2519-EP2371811A2; A15456; 2519-EP2308867A2; 2519-EP2311803A1; 2519-EP2305696A2; 2519-EP2371831A1; 2519-EP2377848A1; 2519-EP2314295A1; 2519-EP2308839A1; 2519-EP2311818A1; 2519-EP2316833A1; 59390-EP2272846A1; 2519-EP2371810A1; 2519-EP2378585A1; 2519-EP2314558A1; 2519-EP2371812A1; 2519-EP2311802A1; 2519-EP2316832A1; 2519-EP2308870A2; 2519-EP2308879A1; 2519-EP2311823A1; 2519-EP2311798A1; 59390-EP2371812A1; 2519-EP2311826A2; 2519-EP2311842A2; 2519-EP2308868A1; 2519-EP2311825A1; 2519-EP2380874A2; 2519-EP2316459A1; 2519-EP2308873A1; 2519-EP2308874A1; 2519-EP2316905A1; 2519-EP2316906A2; 2519-EP2315303A1; 2519-EP2311797A1; 2519-EP2305698A2; 2519-EP2311464A1; 2519-EP2315502A1; 2519-EP2311820A1; 2519-EP2308869A1; 2519-EP2308863A1; 2519-EP2316831A1; 2519-EP2305697A2; 2519-EP2308855A1; 2519-EP2311455A1; BMSE000790; 5-23-04-00191 (beilstein handbook reference); 2519-EP2314575A1; 2519-EP2308861A1; 2519-EP2308562A2; 2519-EP2314582A1; 2519-EP2305769A2; 2519-EP2311830A1; 2519-EP2311827A1; 2519-EP2309584A1; 2519-EP2308832A1; 2519-EP2314574A1; 2519-EP2316470A2; 2519-EP2308852A1; 2519-EP2308833A2; 2519-EP2311451A1; 2519-EP2305808A1; CS-5135; KSC203M9T; glioksal; glyoxaline (archaic); RL02983; RP18283; M-6056; RTR-036369; DB-002018; 7GBN705NH1; AN-23347; ZB015237; CJ-04523; immidazole; AJ-24328; ST2408897; SC-18719; ZINC901039; imidazole, 0.5m buffer solution, ph 7.5; imidazole, 0.5m buffer solution, ph 7.0; imidazole, 0.5m buffer solution, ph 6.0; imidazole, 0.5m buffer solution, ph 6.5; imidazole-buffered saline (5x); DTXSID2029616; mfcd00005183; HY-D0837; F2190-0638; IMZ; Imidazole, ULTROL Grade; Imidazole Glyoxaline; Curezol SIZ; 3-Azapyrrole; Methanimidamide, N,N′-1,2-ethenediyl-;更多
物化数据
  • 密度:1.116
  • 熔点:86-90℃
  • 沸点:90.5 °C
  • 折射率:1.4801
  • 闪光点:145°C c.c.
  • PSA:28.68000
  • LOGP:0.40970
安全信息危险性符号(GHS)  

现货供应各类通用分析试剂、一般化学试剂、高纯试剂,欢迎来电咨询!

联系方式
手机:18627907091
电话:027-5922-8931
Q Q:
Q Q:
手机访问官网
地址:武汉市东西湖区辛安渡工业园43号 电话:027-5922-8931 联系人: 左腾 手机: 18627907091 邮箱: 648231588@qq.com
Copyright © 湖北成丰化工有限公司 XML 技术支持: 食品商务网   盖德化工网